Janus Henderson Investors US’s Aratana Therapeutics, Inc. PETX Stock Holding History

Janus Henderson Investors US’s Portfolio PETX Stock Details PETX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	$7.55M	Sell	1,424,583 -2,353	-0.2%	-$15.9K	0.01%	741
2016 Q4	$10.2M	Buy	1,426,936 +804,753	+129%	+$6.51M	0.01%	715
2016 Q3	$5.82M	Buy	622,183 +590,923	+1,890%	+$4.91M	﹤0.01%	793
2016 Q2	$198K	Sell	31,260 -21,801	-41%	-$140K	﹤0.01%	1173
2016 Q1	$293K	Buy	+53,061	New	+$199K	﹤0.01%	1110

Other funds holding PETX

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Janus Henderson Investors US's PETX Position: Q1 2017 in Review

Janus Henderson Investors US reduced its Aratana Therapeutics, Inc. (PETX) stake by 0.16% in Q1 2017, selling an estimated $15.9K and leaving 1,424,583 shares worth $7.55M. The position accounts for 0.01% of the portfolio, ranked #741.

Janus Henderson Investors US first reported a position in PETX in Q1 2016 and has held it in 5 quarters since. The position peaked at $10.2M in Q4 2016. 98 funds tracked by Wall St. Rank hold PETX as of Q1 2017.

Janus Henderson Investors US held 1,424,583 shares of Aratana Therapeutics, Inc. worth $7.55M as of Q1 2017.
Janus Henderson Investors US sold 2,353 Aratana Therapeutics, Inc. shares in Q1 2017, an estimated $15.9K.
Aratana Therapeutics, Inc. made up 0.01% of Janus Henderson Investors US's portfolio in Q1 2017, its #741 holding.
Janus Henderson Investors US first reported a position in Aratana Therapeutics, Inc. in Q1 2016 and has held it in 5 quarters since.
Janus Henderson Investors US's Aratana Therapeutics, Inc. position peaked at $10.2M in Q4 2016.
98 funds tracked by Wall St. Rank held Aratana Therapeutics, Inc. as of Q1 2017.

Based on Janus Henderson Investors US's 13F filing for Q1 2017, filed 16 May 2017.